Jingzhong Ouyang

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Liver Metastases

Patients Undergoing

Top Venues

Journal of hepatocellular carcinoma

Hepatobiliary surgery and nutrition

Hepatology international

This page only lists publications with an associated author ORCID identifier.

Publications

Yanzhao Zhou, Jingzhong Ouyang, Hongcai Yang, Zhengzheng Wang, Feng Ye, Qingjun Li, Haitao Zhao, Jinxue Zhou, Qiang Li
The Influence of Visceral Adiposity on Overall Survival: Exploring "Obesity Paradox" Among Hepatocellular Carcinoma Patients Who Receiving Immunotherapy. Journal of hepatocellular carcinoma 11 (2024)
Jingzhong Ouyang, Feng Ye, Yanzhao Zhou, Xu Chang, Zhengzheng Wang, Qingjun Li, Yu Tang, Jianqiang Cai, Jinxue Zhou, Zhen Huang, Hong Zhao
Adjuvant camrelizumab plus apatinib in resected hepatocellular carcinoma with microvascular invasion: a multi-center real world study. Hepatobiliary surgery and nutrition 13 (4) (2024)
Yanzhao Zhou, Jingzhong Ouyang, Hongcai Yang, Zhengzheng Wang, Feng Ye, Qingjun Li, Haitao Zhao, Jinxue Zhou, Qiang Li
The Influence of Visceral Adiposity on Overall Survival: Exploring "Obesity Paradox" Among Hepatocellular Carcinoma Patients Who Receiving Immunotherapy. Journal of hepatocellular carcinoma 11 (2024)
Jingzhong Ouyang, Feng Ye, Yanzhao Zhou, Xu Chang, Zhengzheng Wang, Qingjun Li, Yu Tang, Jianqiang Cai, Jinxue Zhou, Zhen Huang, Hong Zhao
Adjuvant camrelizumab plus apatinib in resected hepatocellular carcinoma with microvascular invasion: a multi-center real world study. Hepatobiliary surgery and nutrition 13 (4) (2024)
Jingzhong Ouyang, Yi Yang, Yanzhao Zhou, Feng Ye, Zhengzheng Wang, Qingjun Li, Ying Xu, Lu Li, Xinming Zhao, Wen Zhang, Aiping Zhou, Zhen Huang, Yong Wang, Jianqiang Cai, Hong Zhao, Jinxue Zhou
The MAPS-CRAFITY score: a novel efficacy predictive tool for unresectable hepatocellular carcinoma treated with targeted therapy plus immunotherapy. Hepatology international (2023)
Jingzhong Ouyang, Zhengzheng Wang, Yuan Kun, Feng Ye, Yanzhao Zhou, Qingjun Li, Nanmu Yang, Haitao Zhao, Hong Zhao, Jinxue Zhou
Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark Analysis. Journal of hepatocellular carcinoma 10 (2023)